Aesica Appoints Commercial Managing Director

Article

Aesica appoints Ian Muir to the newly created position of commercial managing director.

Aesica

, a CDMO, has appointed Ian Muir to the newly created position of commercial managing director, effective on February 24. Muir’s responsibilities will cross all three of the company’s service offerings in API manufacturing, formulation development, and formulated products. He will also lead the expansion of the business into new markets, including China and Japan. Muir will report directly to Robert Hardy, CEO, and will be joining the Aesica Board.

Previously, Muir worked at Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms. He also has commercial experience in contract manufacturing roles for pharmaceutical companies located in Europe, the US, and Australia.

Source:

Aesica

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.